Home LiteratureArticle Details
PMID: 30046999 Published · ppublish English Journal Article

Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1.

Journal of molecular neuroscience : MN ·Vol. 65 ·No. 4 ·2018-08-00 ·页码 557-563

Xiao H, Yuan L, Xu H, Yang Z, Huang F, Song Z, Yang Y, Zeng C, Deng H

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder primarily characterized by multiple café-au-lait macules, peripheral neurofibromas, skinfold freckling, and Lisch nodules. The causative genetic factor is the neurofibromin 1 gene (NF1), which encodes a Ras GTPase-activating protein called neurofibromin. NF1 variants may lead to loss of neurofibromin function and activation of downstream cell growth. This study aims to discover the disease-causing variants responsible for NF1 in two Han Chinese families by using exome sequencing combined with Sanger sequencing. A recurrent missense variant c.269T>C (p.Leu90Pro) and a novel nonsense variant c.2993dupA (p.Tyr998*) in the NF1 gene were identified. These variants co-segregated with the disorder in the pedigrees and were absent in the normal controls. The results broaden the NF1 mutation spectrum responsible for NF1. This may be helpful in genetic counseling, clinical management, and gene-targeted therapies for NF1.

Keywords
Gene-targeted therapy Genetic analysis Genetic counseling NF1 gene Neurofibromatosis type 1
MeSH 主题词
Adult Female Humans Male Middle Aged Mutation, Missense Neurofibromatosis 1/genetics,pathology Neurofibromin 1/genetics Pedigree Polymorphism, Single Nucleotide
化学物质
Neurofibromin 1
作者与单位
共 9 位作者,点击展开单位 / ORCID
Xiao Heng
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China. | Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China. | Department of Pathology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Yuan Lamei
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Xu Hongbo
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Yang Zhijian
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Huang Feizhou
Department of Hepatobiliary and Pancreatic Surgery, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Song Zhi
Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Yang Yan
Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Zeng Cheng
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Deng Hao ORCID
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China. hdeng008@yahoo.com. | Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China. hdeng008@yahoo.com.
Article Info
Journal
Journal of molecular neuroscience : MN
Abbr.
J Mol Neurosci
ISSN
1559-1166
Corresponding email
Published
2018-08-00
电子出版
2018-00-25
页码
557-563
Language
English
Country/Region
United States
NLM ID
9002991
基金资助
National Key Research and Development Program of China · 2016YFC1306604
National Natural Science Foundation of China · 81670216
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com